NSN 6505-01-684-9538 · NIIN 016849538 · FSC 6505
NO DASHES 6505016849538
In Stock
TECOVIRIMAT MONOHYDRATE,CAPSULE
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | SMALLPOX TREATMENT, TECOVIRIMAT(TPOXX), 42 CAPSULES, 200MG |
| FEAT | SPECIAL FEATURES | TPOXX IS INDICATED FOR THE TREATMENT OF HUMAN SMALLPOX DISEASE CAUSED BY VARIOLA VIRUS IN ADULTS AND PEDIATRIC PATIENS WEGHING AT LEAST 13 KG(28.66LBS); TPOXX(TECOVIRIMAT) IS AN INHIBITOR OF THE ORTHOPOX VIRUS VP37 ENVELOPE WRAPPING PROTEIN; EACH CAPSULE CONTAINS 200 MG OF TECOVIRIMAT; EACH BOTTLE CONTAINS 42 CAPSULES WITH AN INDUCTION SEAL AND CHILD-RESISTANT CAP; STORE CAPSULES IN THE ORIGINAL BOTTLE AT 20C TO 25C (68F TO 77F); EXCURSIONS PERMITTED 15C TO 30C (59F TO 86F) SEE USP CONTROLLED ROOM TEMPERATURE. |